*Submissions are strictly by invitation only.
Submission Period
December 10 (Tuesday), 2024
–
January 31 (Friday), 2025
February 14 (Friday), 2025
Abstract Submission Guidelines
- Abstracts must be submitted exclusively via this website. Submissions via email or other methods will not be accepted.
- Abstracts will be evaluated by the Scientific Committee.
- Accepted abstracts will be published and distributed at the Conference.
- All submitted abstracts must be original.
- All participants are required to present oral presentations.
- The duration of each presentation will be determined by the review board.
- Abstracts must be submitted by the specified deadline.
Abstract Preparation Guidelines
- The abstract title should be in all uppercase letters and succinctly convey the nature of the investigation.
- Degrees, titles, and appointments of authors should be omitted. The first author listed will be the designated presenter at the Conference.
- Please indicate the city and country where the study originated.
- Presentation style: Oral presentations only
All participants are required to give an oral presentation. The review board will allocate presentation times.
-
Organize the body of the abstract as follows:
a. A brief statement of the purpose of the study
b. A description of the methods used
c. A summary of the results, presented in sufficient detail to support the conclusions
d. The conclusions reached (It is not acceptable to state, "The results will be discussed.")
- Use standard abbreviations; define any unusual abbreviations in parentheses after their first occurrence. Minimize the use of abbreviations.
- Use non-proprietary (generic) names for drugs.
- Keep your abstract concise—limit it to 300 words.
- Caution! Some characters (', ", -, etc.) may not be accepted when copied from a Word file, and you may receive an error message. For these characters, please type them directly in the Abstract Submission Form.
Additionally, for special characters such as ≥ and ±, please replace them with the correct HTML tags listed here: Special Characters List.
- Click the "Abstract Submission" button at the bottom of this page for further instructions.
- For technical difficulties, please contact the Conference Secretariat at: icbtrt2025@convex.co.jp.
Abstracts will be accepted in the following categories
1. |
Basic Science / Molecular Biology / Target Discovery |
2. |
Molecular Pathology / Classification / Biomarkers |
3. |
Genomics / Epigenetics / Bioinformatics |
4. |
Cancer Neuroscience |
5. |
Clinical Trials: Immunologic |
6. |
Clinical Trials: Targeted Therapy |
7. |
Clinical Trials: Other Therapy |
8. |
Viral and Gene Therapy |
9. |
Pediatric Neuro-Oncology |
10. |
Genetic CNS Tumor Syndrome |
11. |
Neuroimaging |
12. |
Neurosurgery |
13. |
Radiation Oncology |
14. |
Drug Delivery |
15. |
Preclinical Experimental Therapeutics / Tumor Models |
16. |
Quality of Life / Survivorship |
17. |
Epidemiology / Health Disparities / Social Determinants of Health |
18. |
Others |
Online Submission
*If you need to review or modify your existing abstract, please click the 'Abstract Submission' button and log in with your ID and password.